Dermatan Sulfate in Pharmaceutical Heparins

Please copy the URL and add it into your RSS Feed Reader.

Facebook X Linkedin Weibo

Download PDF

Thromb Haemost 1987; 58(02): 792
DOI: 10.1055/s-0038-1645973

Letters to the Editor

Schattauer GmbH Stuttgart

A S Perlin

^*The Dept. of Chemistry, McGill University, Montreal, PQ H3A 2A7, Canada

,

F Sauriol

^*The Dept. of Chemistry, McGill University, Montreal, PQ H3A 2A7, Canada

,

B Cooper

^**The Dept. of Physiology, McGill University, Montreal, PQ H3A 2A7, Canada

,

J Folkman

^***The Children’s Hospital, Harvard Medical School, Boston, MA 02115, USA

Further Information

Received 17 February 1987

Accepted after revision 02 April 1987

Publication Date:
27 June 2018 (online)

References
1 Jaques LB. Heparin: An old drug with a new paradigm. Science 1979; 206: 528-533

Crossref PubMed Search in Google Scholar
2 Perlin AS, Mazurek M, Kavanagh LW, Jaques LB. A proton magnetic resonance spectral study of heparin. Carbohydr Res 1978; 7: 369-379

PubMed Search in Google Scholar
3 Perlin AS, Casu B, Sanderson GR, Johnson LF. 220 MHz spectra of heparin, chondroitins, and other mucopolysaccharides. Can J Chem 1970; 48: 2260-2268

Crossref PubMed Search in Google Scholar
4 Folkman J, Langer R, Linhardt RJ, Haudenschild C, Taylor S. Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone. Science 1983; 221: 719-725

Crossref PubMed Search in Google Scholar